Quest Diagnostics saw robust growth in earnings and revenue, surpassing expectations for Q4 2024.Quest Diagnostics (DGX 5.67%), a leader in diagnostic testing and information services, released its fourth quarter results on Jan. 30. The company reported a notable quarter with adjusted earnings per share (EPS) of $2.23, surpassing the analyst projection of $2.18. Additionally, revenue reached $2.62 billion, exceeding the expected $2.58 billion. Overall, Quest had a successful quarter, driven by strategic acq ...